Chemosensitivity to the indoloquinone EO9 is correlated with DT-diaphorase activity and its gene expression

Biochemical Pharmacology
E Smitskamp-WilmsG Giaccone

Abstract

EO9, a new bioreductive indoloquinone alkylating agent, requires activation by a two-electron reduction, which can be catalysed by the NAD(P)H:quinone oxidoreductase DT-diaphorase (DTD) (EC 1.6.99.2). Seven human and four murine tumor cell lines from different histological origins were evaluated for their DTD enzyme activity (evaluated using dichlorophenolindophenol and EO9 as substrates), DTD gene expression and chemosensitivity to EO9. In general the cell lines could be divided into two groups: leukemic cells which were relatively resistant to EO9 (IC50 > or = 0.5 microM) and had no measurable DTD activity, and solid tumor cells, which were more sensitive to the drug (IC50 < 0.06 nM) and contained a high DTD activity (> 90 nmol/min/mg). The expression of the DTD gene was measured by semiquantitative PCR in the human cell lines and an excellent correlation between gene expression and enzyme activity was observed (r2 = 0.94). A higher DTD gene expression also correlated with higher chemosensitivity to EO9. Protection of chemosensitivity to EO9 by dicoumarol, a strong and specific inhibitor of DTD activity, was dependent on duration of exposure and concentration of dicoumarol. Inhibition was best observed by short exposure to di...Continue Reading

References

Sep 1, 1976·Cancer Treatment Reviews·S T Crooke, W T Bradner
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M I WaltonP Workman
Sep 1, 1992·Biochemistry·D SiegelD Ross
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·P Workman
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·M I WaltonP Workman
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·S M BaileyP Workman
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·P WorkmanK L Kooistra
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·G E AdamsS Cole
Mar 1, 1992·British Journal of Cancer·R M PhillipsJ A Double
Apr 15, 1992·Biochemical Pharmacology·R J Riley, P Workman
Aug 5, 1992·Journal of the National Cancer Institute·J H Doroshow
Jan 1, 1991·Free Radical Biology & Medicine·P C PreuschD Ross
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y P KeepersH M Pinedo
Sep 1, 1990·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R M VromansN P Vermeulen
Jun 1, 1968·Canadian Journal of Microbiology·T Yamamoto, C T Chow
Feb 28, 1983·Biochemical and Biophysical Research Communications·R E TalcottV A Levin
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A M BensonP Talalay
May 1, 1980·The Biochemical Journal·Y H EdwardsD A Hopkinson
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N RobertsonI J Stratford
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P E PizaoG Giaccone
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H R HendriksJ A Double
May 28, 1993·International Journal of Cancer. Journal International Du Cancer·G J PetersH M Pinedo
Apr 9, 1962·Biochimica Et Biophysica Acta·L ERNSTERM LJUNGGREN
Jan 1, 1988·IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society·R B Davis

❮ Previous
Next ❯

Citations

Apr 1, 1996·General Pharmacology·E Smitskamp-WilmsG J Peters
Oct 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L Y DirixJ Verweij
Jan 22, 1998·Mutation Research·J B BishopR A Sloane
Nov 27, 2001·Pathophysiology : the Official Journal of the International Society for Pathophysiology·I A. SchepetkinV T. Kagiya
Sep 23, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A M BergmanG J Peters
Apr 19, 2012·British Journal of Pharmacology·Roger M PhillipsUNKNOWN EORTC-Pharmacology and Molecular Mechanism Group
Jul 5, 2005·Expert Opinion on Investigational Drugs·R M Phillips
May 26, 2015·Analytical Chemistry·Bijeta PrasaiRobin L McCarley
Jun 24, 2017·Expert Opinion on Drug Metabolism & Toxicology·R M PhillipsG J Peters
Apr 17, 1999·British Journal of Cancer·M C Bibby
Aug 17, 2021·Frontiers in Oncology·Yue LiXiao-Feng Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
N RobertsonI J Stratford
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
H R HendriksJ A Double
© 2021 Meta ULC. All rights reserved